Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BPM 31510 |
| Trade Name | |
| Synonyms | BPM31510|BPM-31510 |
| Drug Descriptions |
BPM 31510 is a small molecule agent containing a formulation of co-enzyme Q10, thereby affecting metabolism via Warburg effect reversal and thus, potentially resulting in apoptotic activity of cancer cells (Cancer Res 2014;74(19 Suppl):Abstract nr 4321, PMID: 32807842). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C118621 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BPM 31510 | BPM 31510 | 0 | 1 |
| BPM 31510 + Gemcitabine | BPM 31510 Gemcitabine | 0 | 1 |
| BPM 31510 + Temozolomide | BPM 31510 Temozolomide | 0 | 1 |